Jon Moore

Jon Moore is the Chief Scientific Officer (CSO) at Epitopea, a transatlantic RNA immunotherapeutics company focused on developing cancer vaccines.12 Here are some key details about Jon Moore:

Professional Background

Experience and Expertise::

• Jon has over 20 years of experience in the pharmaceutical and biotech industry, primarily in early-stage discovery and validation.12
• He is a biochemist and cell biologist with extensive scientific leadership experience, particularly in oncology.3

Previous Roles::

• Before becoming CSO, Jon served as Epitopea's founding CEO.2
• He is an Operating Partner at Advent Life Sciences, one of Epitopea's founding investors.14
• Jon co-founded both Epitopea and Pheno Therapeutics, a remyelination start-up.3

Education and Skills

Jon Moore holds a PhD in Biochemistry, though the specific institution is not mentioned in the provided search results.3

Contributions to Epitopea

• As the founding CEO, Jon played a crucial role in establishing and guiding Epitopea in its early stages.2
• He recently transitioned from the CEO position to become the company's Chief Scientific Officer, allowing him to focus more on the scientific aspects of Epitopea's work.12

Industry Recognition

Jon is recognized for his detailed knowledge and experience in the oncology space, and is considered exceptionally talented and a valuable asset in the pharmaceutical and biotech industries.5

Jon Moore's LinkedIn profile can be found under the username jon-moore-58829b1, as mentioned in the query.5